ArticleJournal of dental sciences2025
VEGFA promotes odonto/osteoblastic differentiation in dental pulp stem cells via ERK/p38 signaling.
Article in Journal of dental sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advanced Biomaterials for Craniofacial Tissue Regeneration: From Fundamental Mechanism to Translational Applications-A Scoping Review.Journal of functional biomaterials · 2026Review
- Engineered Human Dental Pulp Stem Cells with Promising Potential for Regenerative Medicine.Biotech (Basel (Switzerland)) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Materials and methods: Proliferation, migration, odonto/osteoblastic gene expression, and mineralized nodule formation were evaluated in SHEDs after stimulation with recombinant human VEGFA (rhVEGFA). Expression patterns of extracellular signal-regulated kinase (ERK) and p38/mitogen-activated protein kinase (MAPK) were analysed by western blotting. Rat molar pulp was histologically and immunohistochemically examined after 10 days of rhVEGFA-soaked agarose bead exposure Results: rhVEGFA stimulation promoted migration, mRNA expression of odonto/osteoblastic markers RUNX family transcription factor 2 (RUNX2) and alkaline phosphatase (ALP), and mineralized nodule formation in SHEDs; these effects were reduced by ERK and p38/MAPK inhibitors. RhVEGFA-treated rat molar pulp tissues exhibited a reparative dentin-like mineralized tissue with surrounding nestin-positive cells and densely distributed CD146 Conclusion: rhVEGFA can promote migration, odonto/osteoblastic differentiation, and mineralized nodule formation via ERK/p38 signaling in SHEDs
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.